Overly optimistic design dooms many large randomized trials to failure

Trials published in the best journals are often fatally underpowered, analysis suggests

Academic medicine is a tough business. Conceiving and conducting large randomized controlled trials is an expensive, time-consuming undertaking, requiring intense competition for funding and collaboration by dozens or hundreds of collaborators and facilitators. In an era of diminishing public funding, meaningful clinical research is becoming even more d…